Search

Your search keyword '"Reilly, Cavan"' showing total 578 results

Search Constraints

Start Over You searched for: Author "Reilly, Cavan" Remove constraint Author: "Reilly, Cavan"
578 results on '"Reilly, Cavan"'

Search Results

1. The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants

3. Identifying Paucisymptomatic or Asymptomatic and Unrecognized Ebola Virus Disease Among Close Contacts Based on Exposure Risk Assessments and Screening Algorithms.

4. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

5. Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal cohort study

6. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

7. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

8. Association of Lower Exposure Risk With Paucisymptomatic/Asymptomatic Infection, Less Severe Disease, and Unrecognized Ebola Virus Disease: A Seroepidemiological Study

9. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo

11. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

12. Triangulating Evidence to Infer Pathways that Influence Ebola Virus Disease-Related Stigma and Clinical Findings among Survivors: An Observational Cohort Study.

13. Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study

14. Long-Term Decrease in Intraocular Pressure in Survivors of Ebola Virus Disease in the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Study

15. Initial productive and latent HIV infections originate in vivo by infection of resting T cells

16. Ebola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: An observational cohort study.

17. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

18. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

19. Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

20. Lymphoid Fibrosis Occurs in Long-Term Nonprogressors and Persists With Antiretroviral Therapy but May Be Reversible With Curative Interventions

21. Clonal hematopoiesis of indeterminate potential in persons with HIV

22. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

23. Increased Likelihood of Detecting Ebola Virus RNA in Semen by Using Sample Pelleting

30. Diagnostic performance of LumiraDx SARS-CoV-2 rapid antigen test compared to PCR for diagnosis of COVID-19 in Liberia

35. Prevalence and incidence of transfusion‐transmissible infections among blood donors in Malawi: A population‐level study.

36. Impact of Integrase Inhibition compared to non-nucleoside inhibition on HIV reservoirs in Lymphoid Tissues

37. Lymphoid tissue fibrosis is associated with impaired vaccine responses

39. Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV

41. Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues

43. Diagnostic Performance of Lumiradx Sars-Cov-2 Rapid Antigen Test Compared to Pcr For Diagnosis Of Covid-19 In Liberia

45. Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV

46. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption

47. Antifibrotic Therapy in Simian Immunodeficiency Virus Infection Preserves CD4⁺ T-Cell Populations and Improves Immune Reconstitution With Antiretroviral Therapy

49. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial

50. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Catalog

Books, media, physical & digital resources